TPSi Launches FutureThinker Panel

UK-based healthcare market research agency The Planning Shop international has launched a panel which it claims provides access to the market shapers of the future.

Its new FutureThinker panel offers access to 1,000 clinicians who are 'Key Opinion Leaders' in the US, UK, Germany, France, Italy and Spain.

The panel covers eight speciality areas and 22 indications, to enable pharmaceutical companies to contact the people who are most likely to influence their brand.

The panel builds on the firm's clinician psycho-profiling tool FutureThinker, used to help clients understand the future of their markets, and developed in collaboration with a psychologist.

MD Kim Hughes explains: 'The panel is an initiative that will allow pharmaceutical companies to develop strategy and prioritise tactics based on the feedback of these highly influential opinion formers.'

TPSI is now working with a pharmaceutical database supplier to expand the online panel.

The firm, which has offices in London, Brussels and Jamison, PA in the US, is online at www.planningshopintl.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Planning Shop International Ltd, The
• All news